SCHEMBL5694274

SCHEMBL5694274

[Li]C1C(C)=Cc2c(-c3ccccc3)cccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
BRD4 O60885 1/20 0.33
ALDH1A1 P00352 3/20 0.32
CYP2A6 P11509 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP2B6 P20813 1/20 0.32
HPGD P15428 1/20 0.32
BCL2L1 Q07817 1/20 0.32
MAPK1 P28482 1/20 0.32
USP30 Q70CQ3 1/20 0.32
HTR1A P08908 2/20 0.31
HTR7 P34969 2/20 0.31
HTR2B P41595 2/20 0.31
TMEM97 Q5BJF2 2/20 0.31
SIGMAR1 Q99720 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862311 0.83 BRD9 (0.34) BRD4
SCHEMBL5709148 0.81 PDCD1 (0.34) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL6911211 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL7030356 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL6544268 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL4603520 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL27478125 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL28550963 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL7525652 0.81 PDCD1 (0.36) PDCD1CD274CHRNB2CHRNA4BRD4
SCHEMBL5860442 0.79 METAP2 (0.36) ALDH1A1CYP2A6CYP2B6MAPK1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7081543-B2 Bridged biscyclopentadienyl ligands and method of preparation EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-07-25 US claimed
US-20050250956-A1 Bridged biscyclopentadienyl ligands and method of preparation RIX FRANCIS C 2005-11-10 US claimed
US-6960676-B2 Method of preparing group 14 bridged biscyclopentadienyl ligands EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-11-01 US claimed
EP-1263764-B1 METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS EXXONMOBIL CHEM PATENTS INC (US) 2004-04-14 EP claimed
US-20030220190-A1 Method of preparing group 14 bridged biscyclopentadienyl ligands EXXONMOBIL CHEMICAL PATENTS INC. 2003-11-27 US claimed
EP-1263764-A1 METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS ExxonMobil Chemical Patents Inc. (US) 2002-12-11 EP claimed
WO-2001058913-A1 METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2001-08-16 WO claimed
US-11332553-B2 Catalyst composition for polymerizing polyolefin, method for producing polyolefin, and polyolefin resin DL CHEMICAL CO., LTD. (KR) 2022-05-17 US disclosed
CN-113302211-A Process for preparing catalyst for polymerizing olefins 韩华思路信株式会社 2021-08-24 CN disclosed
CN-108431053-B Composite metallocene supported catalyst, method for producing olefin polymer using the same, and olefin polymer having improved melt strength 韩华化学株式会社 2021-03-30 CN disclosed
EP-3686223-A2 CATALYST COMPOSITION FOR POLYMERIZING POLYOLEFIN, METHOD FOR PRODUCING POLYOLEFIN, AND POLYOLEFIN RESIN Daelim Industrial Co., Ltd. (KR) 2020-07-29 EP disclosed
US-20200231717-A1 CATALYST COMPOSITION FOR POLYMERIZING POLYOLEFIN, METHOD FOR PRODUCING POLYOLEFIN, AND POLYOLEFIN RESIN DL CHEMICAL CO., LTD. (KR) 2020-07-23 US disclosed
CN-108431053-A Composite metallocene supported catalyst, method for producing olefin polymer using the same, and olefin polymer having improved melt strength 韩华化学株式会社 2018-08-21 CN disclosed
WO-2002076999-A1 CATALYSTS CHARACTERIZED BY A DONOR-ACCEPTOR INTERACTION BAYER AKTIENGESELLSCHAFT (DE) 2002-10-03 WO disclosed
WO-2001058913-A1 METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2001-08-16 WO disclosed
EP-0883623-A4 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENT CO (US) 2000-06-28 EP disclosed
EP-0883623-A1 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENTIFIC COMPANY (US) 1998-12-16 EP disclosed
US-5847176-A Preparation of chiral titanocenes BOULDER SCIENTIFIC COMPANY (US) 1998-12-08 US disclosed
WO-1998022477-A1 PREPARATION OF CHIRAL TITANOCENES BOULDER SCIENTIFIC COMPANY (US) 1998-05-28 WO disclosed
EP-0816371-A1 Process for the stereoselective preparation of chiral metallocenes PCD-Polymere Gesellschaft m.b.H. (AT) 1998-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250956-A1 Bridged biscyclopentadienyl ligands and method of preparation FDPS, PPIP5K2, DBF4 PDCD1 398/4885CD274 146/4885CHRNB2 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.